| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/14/2011 | WO2011043147A1 Cell preparation for erectile dysfunction or urinary incontinence containing adipose tissue derived mesenchymal stem cells |
| 04/14/2011 | WO2010081204A3 Polyamine activators ( s permine, s permidine) of the autophagic pathway |
| 04/14/2011 | US20110088106 Compositions and methods for mediating cell cycle progression |
| 04/14/2011 | US20110087025 Method for producing 3-amidinophenylalanine derivatives |
| 04/14/2011 | US20110086907 Acne treatment |
| 04/14/2011 | US20110086905 Pseudocomplementary Oligonucleotides for Targeted Gene Therapy |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086138 Bitter Alkaloid Containing Consumables Comprising Bitter Blockers |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086068 Compositions and Methods for Tissue Engineering, Tissue Regeneration and Wound Healing |
| 04/14/2011 | US20110086019 Polypeptides, antibody variable domains and antagonistsmethods for |
| 04/14/2011 | US20110086014 Method for enzymatic cross-linking of a protein |
| 04/14/2011 | US20110086005 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 04/14/2011 | US20110085993 Use of creatine or creatine compounds for skin preservation |
| 04/14/2011 | US20110085984 Drug Product and Process for Making |
| 04/14/2011 | US20110085980 Cell cycle regulation and differentiation |
| 04/14/2011 | US20110085969 Chelator-targeting ligand conjugates for cardiovascular imaging |
| 04/14/2011 | DE112008003744T5 Fettemulsion, umfassend Ganoderma-Sporenöl, Verfahren zur Qualitätskontrolle und Verwendung davon Fat emulsion comprising Ganoderma spore oil, quality control procedures and use thereof |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308989A2 Pectin hydrolysis products |
| 04/13/2011 | EP2308893A1 Potassium channel mutants of S. cerevisiae and their use for the screening of eucaryotic potassium channels |
| 04/13/2011 | EP2308877A1 Imidazopyridin-2-on derivative |
| 04/13/2011 | EP2308876A1 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 04/13/2011 | EP2308869A1 Azole compound |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308842A1 Pharmaceutical compositions |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308828A2 CaSR antagonist |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors |
| 04/13/2011 | EP2308510A1 Agent for regeneration and/or protection of nerves |
| 04/13/2011 | EP2308509A1 Inhibitor of analgesic tolerance |
| 04/13/2011 | EP2308507A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308323A1 Method for producing an extract of vitis vinifera having high orac values and the extract produced by said method |
| 04/13/2011 | EP2306961A1 Composition and method for enhancing flouride uptake using bioactive glass |
| 04/13/2011 | EP1840208B1 Method of inducing differentiation of skeletal muscle cell |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1939296B Theapolyphenol composition and its preparation |
| 04/13/2011 | CN1842318B Use of biotin or a biotin derivative for lightening skin and treating age spots |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN1665488B Direct cellular energy delivery system |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102016004A Lactic acid bacterium having effect of lowering blood uric acid level |
| 04/13/2011 | CN102015697A Amide derivative and pharmaceutical composition containing the same |
| 04/13/2011 | CN102015660A 2-aminoquinazoline derivative |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015647A Process for production of compound having antagonistic activity on NPYY5 receptor, and useful crystal |
| 04/13/2011 | CN102015641A Heterocyclic compound |
| 04/13/2011 | CN102015638A Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
| 04/13/2011 | CN102014965A PEGylated recombinant human growth hormone compounds |
| 04/13/2011 | CN102014921A Composition for modulating stem cell growth with prostaglandins |
| 04/13/2011 | CN102014920A Eye-drop preparation and use thereof |
| 04/13/2011 | CN102014909A Solid preparation for oral administration |
| 04/13/2011 | CN102014905A Donepezil-containing patch preparation and packaging thereof |
| 04/13/2011 | CN102014889A Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 04/13/2011 | CN102010382A Benzo[d]isoxazol-3-ol daao inhibitors |
| 04/13/2011 | CN102008686A Chinese medicament for treating sarcoidosis |
| 04/13/2011 | CN102008665A Chinese medicament for treating night sweat |
| 04/13/2011 | CN102008663A Oral liquid for preventing heatstroke and reducing temperature for livestock and poultry and preparation method thereof |
| 04/13/2011 | CN102008656A Zaocys dhumnade wine |
| 04/13/2011 | CN102008653A Saliva increasing mixture |
| 04/13/2011 | CN102008647A Traditional Chinese medicine for treating lymphangioleiomyomatosis and preparation method thereof |
| 04/13/2011 | CN102008642A Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine |
| 04/13/2011 | CN102008622A Traditional Chinese medicine for treating atrophy |
| 04/13/2011 | CN102008615A Medicine for treating cystic mass and preparation method thereof |
| 04/13/2011 | CN102008605A Orally-taken Chinese materia medica preparation for treating hydrocele of tunica vaginalis |
| 04/13/2011 | CN102008583A Drug capable of eliminating in-vivo cigarette oil and nourishing throats and preparation method thereof |
| 04/13/2011 | CN102008520A Drug for preventing and treating chronic mountain sickness and preparation method thereof |
| 04/13/2011 | CN102008503A Hematopoietic cells from human embryonic stem cells |
| 04/13/2011 | CN102008407A Composite essential oil for modifying face shape |
| 04/13/2011 | CN101519385B Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 04/13/2011 | CN101461804B (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 04/13/2011 | CN101406654B Oral liquid for treating hoove |
| 04/13/2011 | CN101384549B Pyrrole derivative or salt thereof |
| 04/13/2011 | CN101307049B Alkaloid compounds, method for preparing same and applications as enzyme inhibitors |
| 04/13/2011 | CN101233942B Method for cooking medicinal diet kidney-tonifying yang-invigorating soup |
| 04/13/2011 | CN101151246B 1-benzylindole-2-carboxamide derivatives |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/13/2011 | CN101113141B Optical active N-(alpha-mercapto radical propionyl group) aminoacetic acid |
| 04/13/2011 | CN101049425B Precious medicines of dispersing accumulation of pathogen for treating breast-dripping wet |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/12/2011 | US7923461 TNF-α production inhibitors |
| 04/12/2011 | US7923026 Embedded micellar nanoparticles |
| 04/12/2011 | US7923025 Pharmaceutical composition for oral use with improved absorption |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2481480C Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2473687C Use of polyunsaturated ketones for the treatment of psoriasis |
| 04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| 04/12/2011 | CA2458035C Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/12/2011 | CA2438304C Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |